BNTX
BioNTech SE
NASDAQ: BNTX · HEALTHCARE · BIOTECHNOLOGY
$101.57
-0.48% today
Updated 2026-04-29
Market cap
$25.69B
P/E ratio
—
P/S ratio
8.95x
EPS (TTM)
$-5.50
Dividend yield
—
52W range
$80 – $124
Volume
1.2M
BioNTech SE (BNTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-56.1%
Last 4 quarters
Revenue YoY growth
-24.5%
Most recent quarter
EPS YoY growth
-130.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.2%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-11.1%
2026-03-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-10 | $-0.33 | -33.5% | $102.16 | $90.84 | -11.1% |
| 2025-11-03 | $-0.12 | -220.0% | $103.91 | $104.83 | +0.9% |
| 2025-08-04 | $-1.60 | -13.5% | $107.34 | $111.07 | +3.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.25 | $-0.33 | -33.5% | $898.89M | -24.5% |
| 2025-09-30 | $0.10 | $-0.12 | -220.0% | $1.52B | +22.0% |
| 2025-06-30 | $-1.41 | $-1.60 | -13.5% | $260.80M | +102.6% |
| 2025-03-31 | $-2.35 | $-1.82 | +22.4% | $182.80M | -2.6% |
| 2024-12-31 | $0.48 | $1.08 | +126.6% | $1.19B | -19.5% |
| 2024-09-30 | $-1.70 | $0.88 | +151.8% | $1.24B | +39.0% |
| 2024-06-30 | $-2.02 | $-3.36 | -66.3% | $128.70M | -23.3% |
| 2024-03-31 | $-1.17 | $-1.41 | -20.5% | $187.60M | — |
| 2023-12-31 | $2.42 | $1.90 | -21.5% | $1.48B | — |
| 2023-09-30 | $-0.10 | $0.67 | +770.0% | $895.30M | — |
| 2023-06-30 | $-0.96 | $-0.79 | +17.7% | $167.70M | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $-3.53 | $2.3B | +-20.3% | 13 | high |
| 2027 (E) | $-2.80 | $2.5B | +11.2% | 13 | medium |
| 2028 (E) | $-1.20 | $3.2B | +24.8% | 13 | medium |
| 2030 (E) | $4.20 | $5.7B | +32.4% | 13 | low |
Frequently asked questions
Has BioNTech SE beaten earnings estimates?
BioNTech SE has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -56.1% over the last 4 quarters.
How does BNTX stock react to earnings?
BNTX stock has moved an average of -2.2% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is BioNTech SE's revenue growth rate?
BioNTech SE reported year-over-year revenue growth of -24.5% in its most recent quarter, with EPS growing -130.6% year-over-year.
What is the expected EPS for BNTX in 2026?
Analysts expect BioNTech SE to report EPS of $-3.53 for fiscal year 2026, on revenue of $2.3B, based on estimates from 13 analysts.